LK

Laki Katiyar

Active Director Director DIN 10873998
DIN 10873998 First appointment Dec 2024 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Dec 2024
Shareholding value Locked Premium profile

About Laki Katiyar

Data last updated:

Laki Katiyar has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Kailash Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10873998
Primary Designation Director
First Appointment 16 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Kailash Drugs Private Limited U46497UP2024PTC213418
Director16 Dec 20242024Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kailash Drugs Private Limited
Premium access

Shareholding and investment profile for Laki Katiyar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Laki Katiyar

Laki Katiyar has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Kailash Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Laki Katiyar is associated with 1 company as Director.

Laki Katiyar has expertise in General Business.

Laki Katiyar has 1 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available